96 related articles for article (PubMed ID: 24583863)
1. Improvements of doxorubicin-induced antitumor activity and adverse reaction by combined citrulline.
Miyashita M; Sadzuka Y
Biol Pharm Bull; 2014; 37(3):447-53. PubMed ID: 24583863
[TBL] [Abstract][Full Text] [Related]
2. Effect of linalool as a component of Humulus lupulus on doxorubicin-induced antitumor activity.
Miyashita M; Sadzuka Y
Food Chem Toxicol; 2013 Mar; 53():174-9. PubMed ID: 23220514
[TBL] [Abstract][Full Text] [Related]
3. Theanine and glutamate transporter inhibitors enhance the antitumor efficacy of chemotherapeutic agents.
Sugiyama T; Sadzuka Y
Biochim Biophys Acta; 2003 Dec; 1653(2):47-59. PubMed ID: 14643924
[TBL] [Abstract][Full Text] [Related]
4. Increased effects of MPDAX, a novel xanthine derivative, on antitumor activity of doxorubicin.
Sadzuka Y; Sugiyama T; Suzuki H; Sawanishi H; Miyamoto K
Toxicol Lett; 2004 May; 150(3):341-9. PubMed ID: 15110086
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of curcumin on antitumor activity and adverse reactions of doxorubicin.
Sadzuka Y; Nagamine M; Toyooka T; Ibuki Y; Sonobe T
Int J Pharm; 2012 Aug; 432(1-2):42-9. PubMed ID: 22569233
[TBL] [Abstract][Full Text] [Related]
6. The effect of taurine, a novel biochemical modulator, on the antitumor activity of doxorubicin.
Sadzuka Y; Matsuura M; Sonobe T
Biol Pharm Bull; 2009 Sep; 32(9):1584-7. PubMed ID: 19721236
[TBL] [Abstract][Full Text] [Related]
7. Anserine induced advantage effects on the antitumor activity of doxorubicin.
Sadzuka Y; Sonobe T
Food Chem Toxicol; 2007 Jun; 45(6):985-9. PubMed ID: 17240507
[TBL] [Abstract][Full Text] [Related]
8. C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment.
Prylutska S; Grynyuk I; Matyshevska O; Prylutskyy Y; Evstigneev M; Scharff P; Ritter U
Drugs R D; 2014 Dec; 14(4):333-40. PubMed ID: 25504158
[TBL] [Abstract][Full Text] [Related]
9. Is the combinational administration of doxorubicin and glutathione a reasonable proposal?
Shen BY; Chen C; Xu YF; Shen JJ; Guo HM; Li HF; Li XN; Kang D; Shao YH; Zhu ZP; Yin XX; Xie L; Wang GJ; Liang Y
Acta Pharmacol Sin; 2019 May; 40(5):699-709. PubMed ID: 30218071
[TBL] [Abstract][Full Text] [Related]
10. Palmitoyl ascorbate and doxorubicin co-encapsulated liposome for synergistic anticancer therapy.
Yang Y; Lu X; Liu Q; Dai Y; Zhu X; Wen Y; Xu J; Lu Y; Zhao D; Chen X; Li N
Eur J Pharm Sci; 2017 Jul; 105():219-229. PubMed ID: 28526602
[TBL] [Abstract][Full Text] [Related]
11. The antioxidant phenylaminoethyl selenide reduces doxorubicin-induced cardiotoxicity in a xenograft model of human prostate cancer.
Kang JY; Costyn LJ; Nagy T; Cowan EA; Oldham CD; May SW; Arnold RD
Arch Biochem Biophys; 2011 Nov; 515(1-2):112-9. PubMed ID: 21906582
[TBL] [Abstract][Full Text] [Related]
12. The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel.
Šírová M; Strohalm J; Chytil P; Lidický O; Tomala J; Říhová B; Etrych T
J Control Release; 2017 Jan; 246():1-11. PubMed ID: 27940304
[TBL] [Abstract][Full Text] [Related]
13. Modulation of doxorubicin-induced oxidative stress by a grape (Vitis vinifera L.) seed extract in normal and tumor cells.
Postescu ID; Chereches G; Tatomir C; Daicoviciu D; Filip GA
J Med Food; 2012 Jul; 15(7):639-45. PubMed ID: 22519870
[TBL] [Abstract][Full Text] [Related]
14. Antarth, a polyherbal preparation protects against the doxorubicin-induced toxicity without compromising its Antineoplastic activity.
Jagetia GC; Reddy TK; Malagi KJ; Nayak BS; Naidu MB; Ravikiran PB; Kamath SU; Shetty PC; Reddy DS
Phytother Res; 2005 Sep; 19(9):772-8. PubMed ID: 16220569
[TBL] [Abstract][Full Text] [Related]
15. Effects of water-soluble antioxidant from spinach, NAO, on doxorubicin-induced heart injury.
Breitbart E; Lomnitski L; Nyska A; Malik Z; Bergman M; Sofer Y; Haseman JK; Grossman S
Hum Exp Toxicol; 2001 Jul; 20(7):337-45. PubMed ID: 11530832
[TBL] [Abstract][Full Text] [Related]
16. Synergistic anti-tumor activity through combinational intratumoral injection of an in-situ injectable drug depot.
Kim DY; Kwon DY; Kwon JS; Park JH; Park SH; Oh HJ; Kim JH; Min BH; Park K; Kim MS
Biomaterials; 2016 Apr; 85():232-45. PubMed ID: 26874285
[TBL] [Abstract][Full Text] [Related]
17. Effects of cis-unsaturated fatty acids on doxorubicin sensitivity in P388/DOX resistant and P388 parental cell lines.
Liu QY; Tan BK
Life Sci; 2000; 67(10):1207-18. PubMed ID: 10954054
[TBL] [Abstract][Full Text] [Related]
18. Enhanced efficacy of 1-methyl-3-propyl-7-butylxanthine on the antitumor activity of doxorubicin against doxorubicin-resistant P388 leukemia.
Sadzuka Y; Sugiyama T; Sawanishi H; Miyamoto K
Cancer Lett; 1999 Apr; 138(1-2):5-11. PubMed ID: 10378767
[TBL] [Abstract][Full Text] [Related]
19. Paradoxical inhibition of cardiac lipid peroxidation in cancer patients treated with doxorubicin. Pharmacologic and molecular reappraisal of anthracycline cardiotoxicity.
Minotti G; Mancuso C; Frustaci A; Mordente A; Santini SA; Calafiore AM; Liberi G; Gentiloni N
J Clin Invest; 1996 Aug; 98(3):650-61. PubMed ID: 8698856
[TBL] [Abstract][Full Text] [Related]
20. Molecular and pharmacokinetic properties associated with the therapeutics of bcl-2 antisense oligonucleotide G3139 combined with free and liposomal doxorubicin.
Lopes de Menezes DE; Hudon N; McIntosh N; Mayer LD
Clin Cancer Res; 2000 Jul; 6(7):2891-902. PubMed ID: 10914739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
